시장보고서
상품코드
1472989

세계의 의약품 첨가제 시장 : 유형별, 기능성별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Pharmaceutical Excipients Market Assessment, By Type, By Functionality, By End-user, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 227 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계의 의약품 첨가제 시장 규모는 2024-2031년의 예측 기간 중 7%의 CAGR로 확대하며, 2023년 111억 1,000만 달러에서 2031년에는 190억 8,000만 달러로 성장할 것으로 예측되고 있습니다. 이 시장은 최근 현저한 성장을 달성하고 있으며, 앞으로도 강력한 확대 페이스를 유지할 것으로 예상됩니다.

세계 인구의 만성질환 유병률 증가, 노인 인구 증가 등 다양한 요인이 세계 의약품 첨가제 시장의 성장을 촉진하고 있습니다. 제네릭 의약품에 대한 수요 창출과 공공 및 민간 기업의 투자 및 연구개발 활동이 활발해지면서 시장 성장에 기여하고 있습니다. 또한 유리한 규제 제도, 여러 선도 기업의 존재, 공동 사업 활동, 신규 진입, 빈번한 신제품 출시 등이 세계 의약품 첨가제 시장의 성장을 가속화하고 있습니다.

세계 의약품 부형제 시장은 강력한 성장세를 보이고 있으며, 그 주요 이유는 전 세계 인구의 만성질환 및 감염성 질환이 증가하고 있기 때문입니다. 고령화가 진행됨에 따라 면역력 저하로 인해 만성질환 및 감염성 질환에 걸릴 확률이 높아지면서 이들 질환의 치료용 부형제 등 의약품 수요가 더욱 가속화되고 있습니다. 제약 산업의 성장과 의약품 수요 증가에 대응하기 위한 제네릭 의약품에 대한 수요 증가는 제약사들이 의약품 부형제를 이용한 신약 개발에 대한 투자에 대한 관심 증가로 이어지고 있습니다. 새롭고 효율적인 의약품 부형제를 개발하기 위한 시장 진출기업의 R&D 활동 증가, 유리한 규제 프레임워크, 시장 진출기업의 빈번한 제품 출시는 세계 의약품 부형제 시장을 강화하는 데 매우 중요한 역할을 하고 있습니다. 또한 M&A, 파트너십, 유통 계약과 같은 조직 간의 일관된 협력 활동은 세계 제약 부형제 시장을 더욱 촉진하고 있습니다. 예를 들어 2023년 11월 IFF와 BASF의 제약 솔루션 부문은 IFF의 주요 제약 부형제 브랜드를 BASF의 가상 제약 보조 플랫폼인 ZoomLab에 도입하기 위한 협력을 발표했습니다. 이 플랫폼을 통해 연구자들은 새로운 의약품 제제 개발에 필요한 적절한 부형제를 예측하고 분석하여 제제화 문제를 극복할 수 있습니다.

세계의 의약품 첨가제 시장에 대해 조사했으며, 시장의 개요와 유형별, 기능성별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공하고 있습니다.

목차

제1장 조사 방법

제2장 프로젝트의 범위와 정의

제3장 주요 요약

제4장 세계의 의약품 첨가제 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 유형별
  • 기능성별
  • 최종사용자별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제5장 세계의 의약품 첨가제 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제6장 2023년 시장 매핑

제7장 거시환경과 산업 구조

  • 수요공급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 구조와 혁신

제10장 주요 참여 기업의 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 참여 기업의 전망

  • Kerry Group plc.
  • DFE Pharma GmbH & Co KG
  • Cargill, Incorporated
  • BASF SE
  • Roquette Freres
  • Pfanstiehl Inc.
  • MEGGLE GmbH & Co. KG.
  • The Lubrizol Corporation
  • Avantor, Inc.
  • BENEO GmbH

제14장 전략적 제안

제15장 문의와 면책사항

KSA 24.05.10

Global pharmaceutical excipients market is projected to witness a CAGR of 7% during the forecast period 2024-2031F, growing from USD 11.11 billion in 2023 to USD 19.08 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Various factors, such as the increasing prevalence of chronic diseases among the global population and a rising geriatric population drive growth in the global pharmaceutical excipients market. Growing demand for generic drugs, along with increased investment and research and development activities by public and private firms, leads to the growth of this market. Moreover, a favorable regulatory system, the presence of several top players and collaborative venture activities, new entrants, and frequent new product launches accelerate the growth of the global pharmaceutical excipients market.

The global pharmaceutical excipients market is undergoing robust growth, primarily due to the increased prevalence of chronic and infectious diseases among the global population. The rising aging population increases the probability of being affected by chronic or infectious conditions due to lack of immunity, further accelerating demand for pharmaceutical products such as excipients for treating these diseases. Growth in the pharmaceutical industry and increasing demand for generic drugs to cater to the increasing demand for pharmaceutical products leads to increasing interest among pharmaceutical companies in investing in drug discovery using pharmaceutical excipients. Increased research and development activities by market players to develop new efficient pharmaceutical excipients, favorable regulatory frameworks, and frequent product launches by the market players play a pivotal role in enhancing the global pharmaceutical excipients market. Moreover, consistent collaboration activities such as mergers and acquisitions, partnerships, and distribution agreements between the organizations further propel the global pharmaceutical excipients market. For instance, in November 2023, IFF's and BASF's pharma solutions divisions announced a collaboration to bring IFF's leading pharmaceutical excipients brands on BASF's "ZoomLab", a virtual pharma assistant platform. This platform enables the researchers to predict and analyze the suitable excipients required for developing new pharmaceutical formulations and assists in overcoming formulation challenges.

Increase in Prevalence of Chronic Diseases

The demand for pharmaceutical excipients is increasing significantly due to the rising prevalence of chronic diseases. The increasing aging population is responsible for the onset of several chronic health conditions such as cardiovascular diseases, cancer, and diabetes. These chronic diseases are fatal and need cost-effective solutions to treat these diseases. According to WHO 2023 statistics, chronic diseases are the most common diseases affecting people from all over the world and are responsible for 41 million deaths every year worldwide. A sedentary lifestyle, unhealthy diet, obesity, excessive tobacco, and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases among the population. Pharmaceutical excipients are crucial in optimizing drug delivery formats and developing safe and cost-effective drugs. Moreover, key market players are consistently investing in developing innovative and efficient pharmaceutical excipients to cater to the needs of this growing population suffering from chronic health conditions. This is further accelerating the growth of the global pharmaceutical excipients market.

Increasing Demand for Generic Drugs

With the growing prevalence of chronic and infectious diseases worldwide, there is a huge demand for affordable medicines to cater to the needs of the growing diseased population. Pharmaceutical excipients play a significant role in developing cost-effective and safe generic drugs. As a result, the demand for pharmaceutical excipients is also increasing among the pharmaceutical manufacturers. Several leading pharmaceutical companies are consistently involved in the manufacturing of generic drugs. For instance, Teva Pharmaceutical Industries Ltd., which is a global leader in the pharmaceutical industry states that worldwide, around 200 million people take one of their generic medicines every day and a significant portion of the company's research and development budget is focused on developing generic medicines. This growing interest of the major players in investment activities in generic drugs is anticipated to propel the global pharmaceutical excipients market growth.

Pharmaceutical Companies Hold a Significant Market Share

Based on end-user, the pharmaceutical companies hold a significant share due to frequent product launches by the leading pharmaceutical companies. Furthermore, collaboration ventures such as mergers and acquisitions, and partnership agreements lead to faster growth of the pharmaceutical companies in this market. For instance, in July 2023, Roquette, a strong global player in naturally derived pharmaceutical excipients, announced the acquisition of Qualicaps, a Japan-based pharmaceutical company and the third-largest producer of hard capsules for oral dosage solutions. This strategic acquisition is expected to expand Roquette's global reach and enhance its business of pharmaceutical excipients. These frequent collaboration ventures among pharmaceutical companies bring innovation and advancements in pharmaceutical excipients and drive market growth.

Fillers and Diluents Segment Holds a Significant Market Share

Based on functionality, the fillers and diluents segment holds a significant market share in this market. Pharmaceutical excipient's functionality as a filler plays several important roles during drug formulations, especially in tablet and capsule production. Excipients as a fillers play an essential part in adding bulk to the formulations when the active ingredients are too small. For instance, in October 2023, Roquette, which is a market leader in developing pharmaceutical excipients announced the launch of three new pharmaceutical excipients named "LYCATAB CT-LM" partially pregelatinized starch, "MICROCEL 103 SD" and "MICROCEL 113 SD" microcrystalline cellulose. These excipients are multifunctional, offering functionalities such as binding, filler, and disintegrant that help in the development of drugs.

Asia-Pacific is Expected to be the Fastest Growing Region

Asia-Pacific region is expected to be the fastest-growing region in the global pharmaceutical excipients market. Rapidly increasing population and growing prevalence of chronic and infectious diseases in this region accelerate the demand for pharmaceutical products such as excipients, to improve drug discovery and enhance medical facilities. Asia-Pacific is an emerging market that has huge potential in the pharmaceutical industry, due to which key market players are continuously developing partnership collaborations and establishing operational facilities in this region to expand their business and enhance the overall growth of this market globally. For instance, in February 2022, Azelis, a global leading manufacturer of specialty chemicals, announced the expansion of its pharmaceutical business in India by signing a distribution agreement with Roquette, which is a global leader in providing pharmaceutical excipients. This distribution agreement will strengthen Azelis global footprint, and flourish the pharmaceutical excipients industry in Asia-Pacific.

Future Market Scenario (2024-2031F)

The global pharmaceutical excipients market is expected to grow in the future, due to several factors. Primarily, the increasing prevalence of chronic and infectious diseases is accelerating the demand for pharmaceutical products including excipients in the healthcare sector to provide safe and effective medicines. The growing generic drugs market, along with increased research and development activities by public and private organizations to develop efficient and cost-effective generic drugs by using excipients led to the growth of the global pharmaceutical excipients market. Additionally, frequent product launches, collaboration activities, and new entrants in this market are expected to drive market growth in the forecast period. For instance, in September 2023, IFF's Pharma Solutions announced the launch of leading excipient products such as low nitrite excipient solutions for the pharmaceutical industry. These consistent innovative product launches are expected to accelerate growth in this market.

Key Players Landscape and Outlook

In the pharmaceutical excipients market, several pharmaceutical companies are consistently involved in collaboration activities such as establishing strategic partnerships and undergoing distribution agreements, which play an essential role in propelling the global pharmaceutical excipients market's growth. These partnerships enable companies to gain informative insights on the market trends, access each other's knowledge, resources, markets, and technologies, and invest in research and development activities to bring highly efficient and cost-effective pharmaceutical products such as excipients to the market. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative ventures promote innovation, expedite product development, and contribute to the enduring and robust growth of the global market. For instance, in May 2023, Croda International Plc. announced that it has signed an exclusive license agreement with Amyris to supply biotechnology-derived "squalene" as an excipient to be used for various purposes such as vaccine development, drug delivery systems, or nucleic acid delivery systems. Amyris is a worldwide leading synthetic biology company, which will expedite the commercialization of squalene products to the global market, which will further assist in elevating the global pharmaceutical excipients market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Pharmaceutical Excipients Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Type
    • 4.2.1.Inorganic Chemicals
    • 4.2.2.Organic Chemicals
  • 4.3.By Functionality
    • 4.3.1.Binders and Adhesives
    • 4.3.2.Fillers and Diluents
    • 4.3.3.Coating Material
    • 4.3.4.Flavoring Agent
    • 4.3.5.Disintegrants
    • 4.3.6.Coloring Agents
    • 4.3.7.Preservatives
    • 4.3.8.Buffers
    • 4.3.9.Others
  • 4.4.By End-user
    • 4.4.1.Pharmaceutical Companies
    • 4.4.2.Research Organization and Academics
    • 4.4.3.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Pharmaceutical Excipients Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Type
      • 5.1.2.1.Inorganic Chemicals
      • 5.1.2.2.Organic Chemicals
    • 5.1.3.By Functionality
      • 5.1.3.1.Binders and Adhesives
      • 5.1.3.2.Fillers and Diluents
      • 5.1.3.3.Coating Material
      • 5.1.3.4.Flavoring Agent
      • 5.1.3.5.Disintegrants
      • 5.1.3.6.Coloring Agents
      • 5.1.3.7.Preservatives
      • 5.1.3.8.Buffers
      • 5.1.3.9.Others
    • 5.1.4.By End-user
      • 5.1.4.1.Pharmaceutical Companies
      • 5.1.4.2.Research Organization and Academics
      • 5.1.4.3.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
        • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Type
        • 5.1.5.2.1.Inorganic Chemicals
        • 5.1.5.2.2.Organic Chemicals
      • 5.1.5.3.By Functionality
        • 5.1.5.3.1.Binders and Adhesives
        • 5.1.5.3.2.Fillers and Diluents
        • 5.1.5.3.3.Coating Material
        • 5.1.5.3.4.Flavoring Agent
        • 5.1.5.3.5.Disintegrants
        • 5.1.5.3.6.Coloring Agents
        • 5.1.5.3.7.Preservatives
        • 5.1.5.3.8.Buffers
        • 5.1.5.3.9.Others
      • 5.1.5.4.By End-user
        • 5.1.5.4.1.Pharmaceutical Companies
        • 5.1.5.4.2.Research Organization and Academics
        • 5.1.5.4.3.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Type
  • 6.2.By Functionality
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Kerry Group plc.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.DFE Pharma GmbH & Co KG
  • 13.3.Cargill, Incorporated
  • 13.4.BASF SE
  • 13.5.Roquette Freres
  • 13.6.Pfanstiehl Inc.
  • 13.7.MEGGLE GmbH & Co. KG.
  • 13.8.The Lubrizol Corporation
  • 13.9.Avantor, Inc.
  • 13.10.BENEO GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제